CRISPR Therapeutics AG (CRSP) Net Margin Growth (1y) (2017 - 2026)
CRISPR Therapeutics AG (CRSP) Net Margin Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,491.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,120.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -653.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 447.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | CRISPR Therapeutics AG | 4.57 Bn | 2.12 Bn | - | 728,956.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 728,956.00 |
| Dec 31, 2025 | -1.98 Mn |
| Sep 30, 2025 | 230,296.00 |
| Jun 30, 2025 | 107,287.00 |
| Mar 31, 2025 | 741,209.00 |
| Dec 31, 2024 | 98,268.00 |
| Jun 30, 2024 | -2.43 Mn |
| Mar 31, 2024 | -2.31 Mn |
| Dec 31, 2023 | 184.30 Mn |
| Jun 30, 2023 | 11.75 Mn |
| Mar 31, 2023 | 1.90 Mn |
| Dec 31, 2022 | -184.18 Mn |
| Sep 30, 2022 | -17.03 Mn |
| Jun 30, 2022 | -11.77 Mn |
| Mar 31, 2022 | 192,935.00 |
| Dec 31, 2021 | 2.99 Mn |
| Sep 30, 2021 | 4.70 Mn |
| Jun 30, 2021 | 18.12 Mn |
| Mar 31, 2021 | 2.34 Mn |
| Dec 31, 2020 | -3.10 Mn |